
    
      Clinicians who have experience using low dose fluoroscopy including use of Carto Mapping
      system will consent patients to allow data collection and a 12 month f/up visit to track
      adverse events. Clinicians will follow a protocol which will be similar to their standard of
      care for ablations.
    
  